BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld Asia
Home
» Other news to note for March 31, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for March 31, 2020
March 31, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Akers, Aldeyra, Algernon, Alphamab, Altimmune, Aptorum, Arcturus, Atyr, Beigene, Bellerophon, Benitec, Bioduro, Biogen, Biomérieux, Biosig, BMS, Cansino, Cerecor, Clover, Cobra, Covar, Cytodyn, Dynavax, Eisai, Eli Lilly, Gigagen, Gilead, Grifols, GSK, I-Mab, Imbio, Immuron, IMV, Innoplexus, Inovio, J&J, Kissei, Mabpharm, Mateon, Merck, Novartis, Noveome, Numab, Olix, Ono, Pfizer, Premas, Redhill, Resverlogix, Rising, Sanofi, Sanofi Pasteur, Simcere, Sorrento, Translate Bio, Vaxil, Vero, Vir, Vyripharm, Windtree, Wuxi.
BioWorld Asia
Briefs
Other news to note